GCTK is an unshortable penny med tech stock. It is now overextended and fundamentals do not
support a move higher. Idea is on the chart. Overbought at this point and likely to fall by Friday
as traders take profits for the week.
INBS crush earnings and went parabolic on an earnings beat. Basically, revenues fell but with
belt-tightening and good CEO actions it bled less cash than expected. The tourniquet is
working. The post-earnings pump was followed by a flush to the mid-Fib 0.5 support. Trader's
got their reward and called it a weekend before lunch. The chop index fell into the...
